印度的多发性硬化症：概述
Multiple sclerosis in India: An overview.
作者信息
Singhal Bhim S, Advani Hemali
机构信息
Department of Neurology, Bombay Hospital Institute of Medical Sciences, Marine Lines, Mumbai, Maharashtra, India.
出版信息
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S2-5. doi: 10.4103/0972-2327.164812.
Abstract
Multiple sclerosis (MS) is being increasingly diagnosed in India mainly due to increase in the number of practicing neurologists and easy and affordable availability of magnetic resonance imaging (MRI). The clinical features and course are largely similar to those seen in the West. The term optico-spinal MS (Asian MS) was coined in the pre-MRI days. Many such patients turn out to be cases of neuromyelitis optica - a distinct disorder and not a variant of MS. Others have shown the classical features of MS on MRI scan. Several of the disease-modifying agents, not all, are now available in India. Their use, however, has been limited in view of the high cost.
摘要
在印度，多发性硬化症（MS）的诊断越来越多，这主要归因于执业神经科医生数量的增加以及磁共振成像（MRI）检查便捷且费用可承受。其临床特征和病程在很大程度上与西方所见相似。视神经脊髓型MS（亚洲型MS）这一术语是在MRI出现之前提出的。许多这类患者后来被证实是视神经脊髓炎——一种独特的疾病，而非MS的一种变异型。其他患者在MRI扫描中显示出MS的典型特征。目前，印度已有几种（并非全部）疾病修正治疗药物可供使用。然而，鉴于费用高昂，其使用受到了限制。
相似文献
1
Multiple sclerosis in India: An overview.印度的多发性硬化症：概述
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S2-5. doi: 10.4103/0972-2327.164812.
2
Multiple sclerosis--Indian experience.多发性硬化症——印度的经验
Ann Acad Med Singap. 1985 Jan;14(1):32-6.
3
Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.脑和脊髓病变标准将 AQP4 阳性视神经脊髓炎和 MO G 阳性疾病与多发性硬化症区分开来。
Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.
4
Insights into the changing perspectives of multiple sclerosis in India.印度对多发性硬化症认知视角的变化洞察
Autoimmune Dis. 2011;2011:937586. doi: 10.4061/2011/937586. Epub 2011 Jun 8.
5
Profile of multiple sclerosis in the bombay region. On the basis of critical clinical appraisal.
J Neurol Sci. 1975 Oct;26(2):259-70. doi: 10.1016/0022-510x(75)90038-6.
6
Characterisation of the spectrum of demyelinating disease in Western Australia.西澳大利亚脱髓鞘疾病谱系的特征描述。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1022-6. doi: 10.1136/jnnp.2007.131177. Epub 2008 Mar 20.
7
Magnetic resonance imaging in neuromyelitis optica.视神经脊髓炎的磁共振成像
Mult Scler. 2014 Aug;20(9):1153-64. doi: 10.1177/1352458514531087. Epub 2014 May 14.
8
Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.多发性硬化症和视神经脊髓炎谱系疾病的放射组学。
Eur Radiol. 2019 Sep;29(9):4670-4677. doi: 10.1007/s00330-019-06026-w. Epub 2019 Feb 15.
9
[What are the unique characteristics of optico-spinal MS in Japanese and neuromyelitis optica in western populations].[视神经脊髓型多发性硬化症在日本人群中的独特特征以及视神经脊髓炎在西方人群中的独特特征是什么]
Rinsho Shinkeigaku. 2006 Nov;46(11):863-5.
10
Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.光学相干断层扫描与磁共振成像在多发性硬化症和视神经脊髓炎谱系障碍中的应用
Int J Mol Sci. 2016 Nov 15;17(11):1894. doi: 10.3390/ijms17111894.
引用本文的文献
1
A case series of uveitis in patients with multiple sclerosis.多发性硬化症患者葡萄膜炎的病例系列
Indian J Ophthalmol. 2024 Aug 1;72(8):1223-1224. doi: 10.4103/IJO.IJO_2277_23. Epub 2024 Jul 29.
2
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.多发性硬化症诊断与治疗挑战的细胞和分子证据
J Clin Med. 2023 Jun 26;12(13):4274. doi: 10.3390/jcm12134274.
3
Aneurysmal subarachnoid hemorrhage in a patient with dual autoimmune disorders. Perioperative challenges and management.一名患有双重自身免疫性疾病患者的动脉瘤性蛛网膜下腔出血。围手术期挑战与管理。
J Neurosci Rural Pract. 2023 Apr-Jun;14(2):374-376. doi: 10.25259/JNRP_106_2023. Epub 2023 Apr 10.
4
Etiological and Radiological Spectrum of Longitudinal Myelitis: A Hospital-Based Study in North East India.纵向脊髓炎的病因学和放射学谱：印度东北部一项基于医院的研究
J Neurosci Rural Pract. 2021 Sep 28;12(4):739-744. doi: 10.1055/s-0041-1735826. eCollection 2021 Oct.
5
Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management.印度多发性硬化症的发展态势：管理中的挑战
Ann Indian Acad Neurol. 2018 Apr-Jun;21(2):107-115. doi: 10.4103/aian.AIAN_33_18.
本文引用的文献
1
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.EB 病毒与多发性硬化症：免疫治疗的潜在机会。
Clin Transl Immunology. 2014 Oct 31;3(10):e27. doi: 10.1038/cti.2014.25. eCollection 2014 Oct.
2
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.印度队列中视神经脊髓炎及谱系障碍的临床和影像学特征
Ann Indian Acad Neurol. 2014 Jan;17(1):77-81. doi: 10.4103/0972-2327.128559.
3
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.印度南部芒格洛尔市中枢神经系统脱髓鞘疾病的患病率及模式
Mult Scler. 2014 Oct;20(12):1651-3. doi: 10.1177/1352458514521503. Epub 2014 Feb 3.
4
Association of vitamin D and multiple sclerosis in India.印度维生素 D 与多发性硬化症的关联。
Mult Scler. 2013 Oct;19(12):1592-6. doi: 10.1177/1352458513482375. Epub 2013 Mar 21.
5
Association of Epstein-Barr virus infection with multiple sclerosis in India.印度爱泼斯坦-巴尔病毒感染与多发性硬化症的关联。
J Neurol Sci. 2013 Feb 15;325(1-2):86-9. doi: 10.1016/j.jns.2012.12.004. Epub 2013 Jan 9.
6
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.多发性硬化症的诊断标准：2010 年麦克唐纳标准修订版。
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
7
Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.米托蒽醌作为初始治疗药物在多发性硬化症中的疗效与安全性：印度三级医疗环境中的经验
Neurol India. 2009 Jul-Aug;57(4):418-23. doi: 10.4103/0028-3886.55611.
8
Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.通过紫外线暴露解释多发性硬化症患病率：一项地理空间分析。
Mult Scler. 2009 Aug;15(8):891-8. doi: 10.1177/1352458509105579.
9
Twin studies and the heritability of MS: a conclusion.双胞胎研究与多发性硬化症的遗传度：结论
Mult Scler. 2009 Jun;15(6):661-7. doi: 10.1177/1352458509104592.
10
Revised diagnostic criteria for neuromyelitis optica.视神经脊髓炎修订诊断标准。
Neurology. 2006 May 23;66(10):1485-9. doi: 10.1212/01.wnl.0000216139.44259.74.
Zotero 插件